. The macroscopic features of the lymph node changes are suggestive for reactive hyperplasia. However, it is known that oral melanomas posess a highly malignant biological behavior and micormetastasize early during the course of the disease.
Marginal resection of the soft tissue mass followed by hypofractionated radiative treatment is the current standard with the best reported treatment response in malignant oral melanomas. In this case functionality of the swallowing process and the risk of development of postoperative aspiration pneumonia has to be considered too and may not allow for complete resection but rather cytoreductive surgery.
A new promising tumor autovaccine can be used paralleling the postoperative radiation therapy. An oncology referral center in Switzerland owns the license for use of that autovaccine and can create a contact if desired.